HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Poor prognosis of osteosarcoma of pelvis; 39 years of registration by the Netherlands Commission on Bone Tumors].

AbstractOBJECTIVE:
To evaluate the results of treatment in patients with osteosarcoma of the pelvis.
DESIGN:
Retrospective.
PATIENTS AND METHODS:
Sixty-five patients with pelvic osteosarcoma registered in the files of the Netherlands Committee on Bone Tumours over 1957-1995 were reviewed. Complete information was obtained on 62 cases: 27 males and 35 females, median age was 31 years (range: 12-83). Distant metastases were present in 11 patients (stage IIIB; 18%), while 50 patients had stage IIB osteosarcoma (81%) and 1 patient stage IB osteosarcoma (2%). The results of treatment and survival were determined.
RESULTS:
Median survival was 14 months (2-177), the 5-year survival 15%. Distant metastases developed in 27 of 42 (64%) patients with curatively treated stage IIB osteosarcoma, with prolonged metastasis-free survival after chemotherapy treatment (p < 0.0012). Survival in patients with stage IIB pelvic osteosarcoma was better after surgical resection of the primary tumour than after no operation (p < 0.0054); (neo)adjuvant chemotherapy gave no longer survival than surgery alone (p < 0.083).
CONCLUSION:
The prognosis of pelvic osteosarcoma was poor, despite modern multimodality treatment regimens, including surgical resection and chemotherapy.
AuthorsS J Ham, H M Kroon, H Schraffordt Koops, H J Hoekstra
JournalNederlands tijdschrift voor geneeskunde (Ned Tijdschr Geneeskd) Vol. 144 Issue 3 Pg. 121-5 (Jan 15 2000) ISSN: 0028-2162 [Print] Netherlands
Vernacular TitleSlechte prognose van bekkenosteosarcoom; 39 jaar registratie door de Nederlandse Commissie voor Beentumoren.
PMID10674118 (Publication Type: English Abstract, Journal Article)
Topics
  • Adolescent
  • Adult
  • Aged
  • Bone Neoplasms (mortality, radiotherapy, surgery, therapy)
  • Child
  • Combined Modality Therapy
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Netherlands (epidemiology)
  • Osteosarcoma (mortality, radiotherapy, secondary, surgery, therapy)
  • Pelvic Bones (surgery)
  • Prognosis
  • Registries (statistics & numerical data)
  • Retrospective Studies
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: